As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

The survey suggests ads can improve health management. Almost half of patients said ads help them make informed decisions ...

Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...

A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

As Hurricane Milton made landfall in Florida Wednesday night, drugmakers, regulators, hospitals and health agencies alike ...

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...